Rating History for Ligand Pharma (LGND) by Barclays

More Stocks Rated by Barclays | Latest Ratings for LGND
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/25/2026 Glen Santangelo New Coverage Overweight
(N/A)		 345.00
(N/A)		 298.41
(314.78)		 5.49% Details